Email updates

Keep up to date with the latest news and content from BMC Urology and BioMed Central.

Open Access Case report

Primary PEComa of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report

Jeremy R Parfitt1*, Anthony J Bella2, Bret M Wehrli1 and Jonathan I Izawa2

Author Affiliations

1 Department of Pathology, London Health Sciences Centre and University of Western Ontario, London, Canada

2 Department of Surgery, Division of Urology, London Health Sciences Centre and University of Western Ontario, London, Canada

For all author emails, please log on.

BMC Urology 2006, 6:20  doi:10.1186/1471-2490-6-20

Published: 22 August 2006

Abstract

Background

Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms of uncertain malignant potential, which have in common the co-expression of muscle and melanocytic immunohistochemical markers.

Case presentation

A 48-year-old man presented with dysuria, passage of urinary sediment and lower abdominal discomfort. A three centimeter mass was identified by cystoscopy in the posterior midline of the bladder. Computerized tomography suggested an enterovesical fistula. The patient underwent laparotomy, partial cystectomy and partial small bowel resection. Pathological examination revealed PEComa of the bladder. The patient underwent adjuvant interferon-α immunotherapy. Subsequent follow-up procedures, including cystoscopy and imaging, have not revealed evidence of recurrence. The patient is clinically free of disease 48 months after surgery.

Conclusion

This case represents the second documented PEComa of bladder and demonstrates that adjuvant therapies, including anti-angiogenic and immunotherapy, may be considered for patients with locally advanced or metastatic genitourinary PEComa.